Calidi Biotherapeutics, Inc. (CLDI) is a publicly traded Healthcare sector company. As of May 21, 2026, CLDI trades at $0.17 with a market cap of $2.79M and a P/E ratio of -0.03. CLDI moved -8.04% today. Year to date, CLDI is -85.53%; over the trailing twelve months it is -96.84%. Its 52-week range spans $0.16 to $46.68. Rallies surfaces CLDI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Calidi Biotherapeutics, Inc. (CLDI) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CLDI moved -8.04% today.
| Metric | Value |
|---|---|
| Price | $0.17 |
| Market Cap | $2.79M |
| P/E Ratio | -0.03 |
| EPS | $-5.95 |
| Dividend Yield | 0.00% |
| 52-Week High | $46.68 |
| 52-Week Low | $0.16 |
| Volume | 1.70M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-20.06M |
| Gross Margin | 0.00% |
CLDI analyst coverage data. Average price target: $0.00.